参考文献/References:
[1] NEIFERT S N,CHAPMAN E K,MARTINI M L,et al.Aneurysmal subarachnoid hemorrhage:The last decade[J].Transl Stroke Res,2021,12(3):428-446.
[2] HOH B L,KO N U,AMIN-HANJANI S,et al.2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage:A guideline from the American Heart Association/American Stroke Association[J].Stroke,2023,54(7):e314-e370.
[3] ADDIS A,BAGGIANI M,CITERIO G.Intracranial pressure monitoring and management in aneurysmal subarachnoid hemorrhage[J].Neurocrit Care,2023,39(1):59-69.
[4] GONG C,SUN M S,LENG R,et al.Endovascular embolization of visceral artery aneurysm:A retrospective study[J].Sci Rep,2023,13(1):6936.
[5] KUO L T,HUANG A P.The pathogenesis of hydrocephalus following aneurysmal subarachnoid hemorrhage[J].Int J Mol Sci,2021,22(9):5050.
[6] 唐剑,陈双华,何凌.骨髓间充质干细胞来源外泌体对大鼠脊髓损伤的改善作用及对脊髓组织胞浆型磷脂酶A2、水通道蛋白4和水通道蛋白9的影响实验研究[J].陕西医学杂志,2023,52(12):1654-1659.
[7] KITCHEN P,SALMAN M M,HALSEY A M,et al.Targeting aquaporin-4 subcellular localization to treat central nervous system edema[J].Cell,2020,181(4):784-799.
[8] ZHAO X,KRUZEL M,ARONOWSKI J.Lactoferrin and hematoma detoxification after intracerebral hemorrhage[J].Biochem Cell Biol,2021,99(1):97-101.
[9] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组.中国蛛网膜下腔出血诊治指南2019[J].中华神经科杂志,2019,52(12):1006-1021.
[10] 黄永健,麦玲,罗婷,等.颅内动脉瘤血管内介入术后慢性脑积水患者血清CCCK-18、Netrin-1、HPA水平变化及意义[J].山东医药,2023,63(10):31-35.
[11] 伍学斌,曾胜田,彭远强,等.神经内镜下第三脑室底造瘘术联合脑室-腹腔分流术治疗高血压脑出血术后慢性正常压力脑积水的效果分析[J].中国脑血管病杂志,2023,20(6):398-404.
[12] 李泽新,张贝贝.血清缺氧诱导因子-1α、前列腺素E2水平与动脉瘤性蛛网膜下腔出血关系及对脑血管痉挛的预测价值[J].陕西医学杂志,2023,52(2):141-144,191.
[13] 袁晓东,吴过,熊建平,等.动脉瘤性蛛网膜下腔出血后慢性脑积水形成的相关因素分析[J].实用心脑肺血管病杂志,2015(5):59-61.
[14] CZORLICH P,SCHWEINGRUBER N,GÖTTSCHE J,et al.Acute low-pressure hydrocephalus in aneurysmal subarachnoid hemorrhage[J].Neurosurg Focus,2023,54(4):e5.
[15] ZHENG R Z,XU Z,WANG Z,et al.Clinical characteristics of and treatment strategy for hydrocephalus in patients with severe disorders of consciousness[J].J Neurotrauma,2023,40(13-14):1402-1414.
[16] 刘宙.成人脑室内出血并发慢性脑积水的研究进展[J].中国微侵袭神经外科杂志,2020,25(1):46-48.
[17] 曹晓璐,揣春阳,周梦,等.动脉瘤性蛛网膜下腔出血介入栓塞术后并发脑积水的危险因素分析[J].中国临床实用医学,2024,15(1):23-28.
[18] DI-RUSSO P,DI-CARLO D T,LUTENBERG A,et al.Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage[J].J Neurosurg Sci,2020,64(2):181-189.
[19] ZOLLER H,WOLF M,BLUMENSTEIN I,et al.Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease(PHOSPHARE-IBD):A randomised clinical trial[J].Gut,2023,72(4):644-653.
[20] LI C Q,XING Y,ZHANG Y Q,et al.Neutrophil extracellular traps exacerbate ischemic brain damage[J].Mol Neurobiol,2022,59(1):643-656.
[21] 姚亚妮,罗鑫宇,冯婷婷,等.帕金森病患者外周铁代谢与炎症因子、临床症状及病情严重程度的相关性研究[J].新疆医科大学学报,2023,46(12):1575-1579.
[22] YANG L Y,CHEN Y R,LEE J E,et al.Dental pulp stem cell-derived conditioned medium alleviates subarachnoid hemorrhage-induced microcirculation impairment by promoting M2 microglia polarization and reducing astrocyte swelling[J].Transl Stroke Res,2023,14(5):688-703.
[23] LAPSHINA K V,EKIMOVA I V.Aquaporin-4 and Parkinson's disease[J].Int J Mol Sci,2024,25(3):1672.
[24] 汪文兵,陈后勤,徐钧,等.血清AQP4、GFAP联合检测对急性缺血性脑卒中患者静脉溶栓后出血性转化的预测价值[J].临床误诊误治,2022,35(5):102-105.
[25] SALMAN M M,KITCHEN P,HALSEY A,et al.Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis[J].Brain,2022,145(1):64-75.
[26] LI Y,NAN D,LIU R,et al.Aquaporin 4 mediates the effect of iron overload on hydrocephalus after intraventricular hemorrhage[J].Neurocrit Care,2024,40(1):225-236.
[27] 刘胜,李明昌.蛛网膜下腔出血的脑损伤机制及相关生物标志物研究进展[J].国际神经病学神经外科学杂志,2023,50(3):51-59.